Grants Awarded

The number of grants awarded by the Histiocytosis Association varies each year. It is determined by a variety of factors including, but not limited to, the quality of eligible applications received and the availability of funds.

Use the filters below to see information for all of the research projects the Association has funded since 1992.

To filter by year and disease type, select the year first.

All
  • All
  • HLH/FEL/FHL
  • LCH
  • Rare Histiocytic Disorders and Other Topics

Use of a Response-Adapted Ruxolitinib-Containing Regimen for the Treatment of Hemophagocytic Lymphohistiocytosis

Melissa Hines St Jude Children’s Research Hospital, Memphis, TN USA

Read More

Developmental Hierarchy in LCH

Principal Investigator Caroline Hutter St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2018 Amount of Award…

Read More

Understanding the role of Epstein Barr virus in Hemophagocytic Lymphohistiocytosis

Principal Investigator Claire Shannon-Lowe The University of Birmingham Birmingham, United Kingdom Date of Award December 2018 Amount of…

Read More

Unbiased profiling of the hemophagocytic lymphohistiocytic syndrome by high-throughput single-cell transcriptomic analysis

Principal Investigator Fernando Sepulveda INSERM DR Paris 5 Paris, France Date of Award December 2018 Amount of Award…

Read More

The mechanisms of cytotoxic granule exocytosis underlying hemophagocytic lymphohistiocytosis

Principal Investigator Shuzo Sugita University Health Network Toronto, ON Canada Date of Award December 2018 Amount of Award…

Read More

Maintenance of the IT platform of the LCH-IV Treatment Protocol Study (LCH-IVTPS)

Principal Investigator Milen Minkov CCRI, St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2017 Amount of…

Read More

A Study of Advanced Neuroimaging and Cognition in Adults with Histiocytic Disorders

Principal Investigator Eli Diamond, M.D. Memorial Sloan Kettering Cancer Center New York, NY USA Date of Award…

Read More

The use of a newly generated murine model to determine the broad role of STXBP2 in FHL5 pathogenesis

Principal Investigator Fernando Sepulveda, Ph.D. Imagine Institute Paris, France Date of Award December 2016 Amount of Award…

Read More

HIF-1α Signaling is a Central Pathobiologic Mediator of Hemophagocytic Lymphohistiocytosis

Principal Investigator Gang Huang, Ph.D. Children’s Hospital Medical Center Cincinnati, OH USA Date of Award December 2016…

Read More